SWTX
Price
$48.52
Change
-$1.03 (-2.08%)
Updated
Mar 10, 03:16 PM (EDT)
Capitalization
3.71B
52 days until earnings call
XENE
Price
$34.62
Change
-$1.88 (-5.15%)
Updated
Mar 10, 03:26 PM (EDT)
Capitalization
2.79B
64 days until earnings call
Ad is loading...

SWTX vs XENE

Header iconSWTX vs XENE Comparison
Open Charts SWTX vs XENEBanner chart's image
SpringWorks Therapeutics
Price$48.52
Change-$1.03 (-2.08%)
Volume$1.2K
Capitalization3.71B
Xenon Pharmaceuticals
Price$34.62
Change-$1.88 (-5.15%)
Volume$2K
Capitalization2.79B
SWTX vs XENE Comparison Chart
Loading...
SWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SWTX vs. XENE commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SWTX is a Buy and XENE is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (SWTX: $51.38 vs. XENE: $36.02)
Brand notoriety: SWTX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SWTX: 79% vs. XENE: 145%
Market capitalization -- SWTX: $3.63B vs. XENE: $2.62B
SWTX [@Biotechnology] is valued at $3.63B. XENE’s [@Biotechnology] market capitalization is $2.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SWTX’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 2 green FA rating(s).

  • SWTX’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 2 green, 3 red.
According to our system of comparison, XENE is a better buy in the long-term than SWTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SWTX’s TA Score shows that 5 TA indicator(s) are bullish while XENE’s TA Score has 3 bullish TA indicator(s).

  • SWTX’s TA Score: 5 bullish, 5 bearish.
  • XENE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SWTX is a better buy in the short-term than XENE.

Price Growth

SWTX (@Biotechnology) experienced а -4.90% price change this week, while XENE (@Biotechnology) price change was -4.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

SWTX is expected to report earnings on May 01, 2025.

XENE is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SWTX($3.71B) has a higher market cap than XENE($2.79B). SWTX YTD gains are higher at: 42.209 vs. XENE (-8.112). XENE has higher annual earnings (EBITDA): -252.74M vs. SWTX (-274.66M). XENE has more cash in the bank: 654M vs. SWTX (308M). SWTX has less debt than XENE: SWTX (7.91M) vs XENE (9.79M). SWTX has higher revenues than XENE: SWTX (192M) vs XENE (0).
SWTXXENESWTX / XENE
Capitalization3.71B2.79B133%
EBITDA-274.66M-252.74M109%
Gain YTD42.209-8.112-520%
P/E RatioN/AN/A-
Revenue192M0-
Total Cash308M654M47%
Total Debt7.91M9.79M81%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
21
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SWTXXENE
RSI
ODDS (%)
Bearish Trend 7 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
82%
Momentum
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
81%
MACD
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
86%
Bearish Trend 7 days ago
75%
Advances
ODDS (%)
Bullish Trend 28 days ago
82%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 8 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 7 days ago
86%
Aroon
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 7 days ago
77%
View a ticker or compare two or three
Ad is loading...
SWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

SWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SWTX has been loosely correlated with RIGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SWTX jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWTX
1D Price
Change %
SWTX100%
-3.57%
RIGL - SWTX
41%
Loosely correlated
-1.30%
IMNM - SWTX
36%
Loosely correlated
+0.45%
BEAM - SWTX
35%
Loosely correlated
+5.34%
SANA - SWTX
34%
Loosely correlated
+5.35%
AXSM - SWTX
34%
Loosely correlated
-1.24%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
+0.64%
KYMR - XENE
46%
Loosely correlated
+1.69%
IDYA - XENE
42%
Loosely correlated
-1.78%
RCKT - XENE
42%
Loosely correlated
-1.48%
AURA - XENE
42%
Loosely correlated
+4.02%
CRNX - XENE
42%
Loosely correlated
-0.23%
More